Delivery Order SPE2DB20D2104-SPE2DB25FMBKH
Award Date
10/28/24
Potential Completion Date
10/29/24
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $51,098.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order awarded under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of $999,999,999 and runs through November 2026. The DLA IDC serves as a primary mechanism for AmerisourceBergen to provide a comprehensive...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,028.36 firm-fixed-price delivery order is for the medication Trelegy Ellipta, a combination inhaled medication used to treat chronic obstructive pulmonary disease (COPD). The delivery order has a completion date of May 7, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order worth $5,248.75 from the Defense Logistics Agency (DLA). The award is for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has a completion date of May 1, 2023 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,108.93 firm-fixed-price delivery order is for the medication Trelegy Ellipta, a combination treatment for chronic obstructive pulmonary disease. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,406.85 Firm Fixed Price Delivery Order is for the supply of Trelegy Ellipta, a prescription medication used to treat chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of December 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $4,106.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,320.69 delivery order is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a medication used for the treatment of chronic obstructive pulmonary disease (COPD). The contract has a firm fixed price and an ultimate completion date of July 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award is a delivery order valued at $10,664.36 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a period of performance through December 27, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,074.51 firm fixed-price delivery order is for the medication Trelegy Ellipta, a combination treatment for chronic obstructive pulmonary disease. The contract has an ultimate completion date of April 17, 2025 and is not a set-aside. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,273.50 firm fixed-price delivery order is for TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of June 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...